{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:07:34Z","timestamp":1791191254734,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":2494,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1111\/ajt.13476","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T12:09:06Z","timestamp":1444910946000},"page":"603-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts"],"prefix":"10.1016","volume":"16","author":[{"given":"J.G.","family":"O\u2019Leary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Banuelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.W.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kaneku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.I.","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.","family":"Klintmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Demetris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.13476_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.smim.2011.09.002","article-title":"Chronic alloantibody mediated rejection","volume":"24","author":"Smith","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1111\/ajt.13476_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/ajt.13476_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/ajt.12667","article-title":"The role of donor-specific HLA alloantibodies in liver transplantation","volume":"14","author":"O\u2019Leary","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.1840210519","article-title":"Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance","volume":"21","author":"Manez","year":"1995","journal-title":"Hepatology"},{"issue":"Pt 1","key":"10.1111\/ajt.13476_bib5","first-page":"396","article-title":"Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy","volume":"23","author":"Takaya","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.13476_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00007890-199202010-00026","article-title":"The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors","volume":"53","author":"Takaya","year":"1992","journal-title":"Transplantation"},{"issue":"Pt 2","key":"10.1111\/ajt.13476_bib7","first-page":"888","article-title":"Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation","volume":"25","author":"Manez","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.13476_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-6143.2011.03786.x","article-title":"Re-examination of the lymphocytotoxic crossmatch in liver transplantation: Can C4d stains help in monitoring?","volume":"12","author":"Lunz","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.23687","article-title":"Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation","volume":"19","author":"O\u2019Leary","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-0012.1989.tb00531.x","article-title":"Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys","volume":"3","author":"Starzl","year":"1989","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.13476_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/lt.22233","article-title":"Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies","volume":"17","author":"Kozlowski","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2007-1007376","article-title":"Immunopathology of antibodies as effectors of orthotopic liver allograft rejection","volume":"12","author":"Demetris","year":"1992","journal-title":"Semin Liver Dis"},{"key":"10.1111\/ajt.13476_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840160310","article-title":"A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies","volume":"16","author":"Demetris","year":"1992","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13476_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/lt.23403","article-title":"Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: Diagnostic considerations in the evaluation of liver allografts","volume":"18","author":"Kozlowski","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/lt.23948","article-title":"Acute liver allograft antibody-mediated rejection: An inter-institutional study of significant histopathological features","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib16","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation","volume":"12","author":"Paterno","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/lt.23788","article-title":"Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ajt.12651","article-title":"Prevalence incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients","volume":"14","author":"Del Bello","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib19","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1600-6143.2012.03995.x","article-title":"Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year","volume":"12","author":"Taner","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/lt.23707","article-title":"Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation","volume":"19","author":"Musat","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.humimm.2009.12.002","article-title":"Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies","volume":"71","author":"Girnita","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1111\/ajt.13476_bib23","unstructured":"Feng S, Demetris AJ, Ekong U, et al. Serum and tissue DSA subclass, stellate and endothelial phenotype monitoring in ITN029ST tolerance pediatric liver transplant recipients over 5+ years of follow-up. Abstract presented at: International Liver Transplant Society Meeting; 2014 London."},{"key":"10.1111\/ajt.13476_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jama.2011.2014","article-title":"Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants","volume":"307","author":"Feng","year":"2012","journal-title":"JAMA"},{"key":"10.1111\/ajt.13476_bib25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.13153","article-title":"Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation","volume":"15","author":"O\u2019Leary","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/lt.23854","article-title":"Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.12659\/AOT.892544","article-title":"Immunological factors and liver fibrosis in pediatric liver transplant recipients","volume":"20","author":"Markiewicz-Kijewska","year":"2015","journal-title":"Ann Transplant"},{"key":"10.1111\/ajt.13476_bib28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts","volume":"18","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/lt.23789","article-title":"Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation","volume":"20","author":"Salah","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1872-034X.2012.01003.x","article-title":"Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal","volume":"42","author":"Egawa","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1111\/ajt.13476_bib31","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/TP.0000000000000185","article-title":"Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal","volume":"98","author":"Ohe","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13476_bib32","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/TP.0000000000000613","article-title":"Donor-specific anti-HLA antibodies and endothelial C4d deposition\u2014Association with chronic liver allograft failure","volume":"99","author":"Iacob","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13476_bib33","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2011.03593.x","article-title":"High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant","volume":"11","author":"O\u2019Leary","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib34","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1097\/TP.0000000000000638","article-title":"Long-term clinical relevance of de novo donor-specific antibodies after pediatric liver transplantation","volume":"99","author":"Grabhorn","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13476_bib35","first-page":"550","article-title":"Long-term immunosuppression management in OLT recipients","volume":"7","author":"Tchao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib36","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.23451","article-title":"Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation","volume":"18","author":"Kaneku","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13476_bib37","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/j.1600-6143.2012.04210.x","article-title":"Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children","volume":"12","author":"Venturi","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MOT.0b013e3283615d48","article-title":"Tissue biopsy monitoring of operational tolerance in liver allograft recipients","volume":"18","author":"Demetris","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/ajt.13476_bib39","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/01.ASN.0000061778.08085.9F","article-title":"Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: Characterization, isolation, and regulation of MHC class II expression","volume":"14","author":"Muczynski","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13476_bib40","first-page":"673","article-title":"Antigenic heterogeneity of vascular endothelium","volume":"141","author":"Page","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1111\/ajt.13476_bib41","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.26426","article-title":"Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients","volume":"58","author":"Benitez","year":"2013","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13476_bib42","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1399-3046.2012.01781.x","article-title":"Humoral immunity is involved in the development of pericentral fibrosis after pediatric live donor liver transplantation","volume":"16","author":"Yamada","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1111\/ajt.13476_bib43","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib44","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","article-title":"Banff 2011 Meeting report: New concepts in antibody-mediated rejection","volume":"12","author":"Mengel","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007890-198802000-00030","article-title":"Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation","volume":"45","author":"Steinhoff","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13476_bib47","first-page":"35","article-title":"HLA-A,B,C, HLA-D\/DR and HLA-D\/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease","volume":"70","author":"Ballardini","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/ajt.13476_bib48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/jcp.40.8.879","article-title":"Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man","volume":"40","author":"Barbatis","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1111\/ajt.13476_bib49","first-page":"82","article-title":"Early induction of MHC antigens in human liver grafts","volume":"133","author":"Gouw","year":"1988","journal-title":"An immunohistologic study. Am J Pathol"},{"key":"10.1111\/ajt.13476_bib50","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/ajt.12147","article-title":"Class II alloantibody and mortality in simultaneous liver-kidney transplantation","volume":"13","author":"O\u2019Leary","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib51","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1600-6143.2011.03467.x","article-title":"Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver\/kidney transplants","volume":"11","author":"Dar","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.1840090207","article-title":"A histometric analysis of chronically rejected human liver allografts: Insights into the mechanisms of bile duct loss: Direct immunologic and ischemic factors","volume":"9","author":"Oguma","year":"1989","journal-title":"Hepatology"},{"issue":"Pt 2","key":"10.1111\/ajt.13476_bib53","first-page":"1409","article-title":"Peribiliary vascular diseases in rejected livers; computer-aided three-dimensional reconstruction and morphometry","volume":"23","author":"Takemura","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.13476_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00007890-199307000-00012","article-title":"Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection","volume":"56","author":"Matsumoto","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13476_bib55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1600-6143.2011.03821.x","article-title":"Transplant accommodation\u2014Are the lessons learned from xenotransplantation pertinent for clinical allotransplantation?","volume":"12","author":"Dorling","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00007890-199707270-00014","article-title":"Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: A report of the U.S. Multicenter Liver Study Group","volume":"64","author":"Sher","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13476_bib57","doi-asserted-by":"crossref","unstructured":"O\u2019Leary JG, Samaniego M, Barrio MC, et al. The influence of immunosuppressive agents on the risk of de novo donor-specific HLA antibody production in solid organ transplant recipients. Transplantation. 2015; In press.","DOI":"10.1097\/TP.0000000000000869"},{"key":"10.1111\/ajt.13476_bib58","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.13153","article-title":"Impact of IgG3 subclass and C1q-fixing donor-specific HLA antibodies on rejection and survival in liver transplantation","volume":"15","author":"O\u2019Leary","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13476_bib59","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/eji.200838189","article-title":"The IFN-gamma-induced transcriptional program of the CIITA gene is inhibited by statins","volume":"38","author":"Lee","year":"2008","journal-title":"Eur J Immunol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13476","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522005937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522005937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:13:01Z","timestamp":1761628381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522005937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1600613522005937"],"URL":"https:\/\/doi.org\/10.1111\/ajt.13476","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.13476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}